Your browser doesn't support javascript.
loading
Tumor microenvironment defines the invasive phenotype of AIP-mutation-positive pituitary tumors.
Barry, Sayka; Carlsen, Eivind; Marques, Pedro; Stiles, Craig E; Gadaleta, Emanuela; Berney, Dan M; Roncaroli, Federico; Chelala, Claude; Solomou, Antonia; Herincs, Maria; Caimari, Francisca; Grossman, Ashley B; Crnogorac-Jurcevic, Tatjana; Haworth, Oliver; Gaston-Massuet, Carles; Korbonits, Márta.
Afiliación
  • Barry S; Centre for Endocrinology, William Harvey Research Institute, Barts and The London School of Medicine, Queen Mary University of London, London, EC1M 6BQ, UK.
  • Carlsen E; Department of Pathology, STHF, N-3710, Skien, Norway.
  • Marques P; Centre for Endocrinology, William Harvey Research Institute, Barts and The London School of Medicine, Queen Mary University of London, London, EC1M 6BQ, UK.
  • Stiles CE; Centre for Endocrinology, William Harvey Research Institute, Barts and The London School of Medicine, Queen Mary University of London, London, EC1M 6BQ, UK.
  • Gadaleta E; Molecular Oncology, Barts Cancer Institute, Barts and The London School of Medicine, Queen Mary University of London, London, EC1M 6BQ, UK.
  • Berney DM; Molecular Oncology, Barts Cancer Institute, Barts and The London School of Medicine, Queen Mary University of London, London, EC1M 6BQ, UK.
  • Roncaroli F; Division of Neuroscience & Experimental Psychology, University of Manchester, Manchester, M13 9PL, UK.
  • Chelala C; Molecular Oncology, Barts Cancer Institute, Barts and The London School of Medicine, Queen Mary University of London, London, EC1M 6BQ, UK.
  • Solomou A; Centre for Endocrinology, William Harvey Research Institute, Barts and The London School of Medicine, Queen Mary University of London, London, EC1M 6BQ, UK.
  • Herincs M; Centre for Endocrinology, William Harvey Research Institute, Barts and The London School of Medicine, Queen Mary University of London, London, EC1M 6BQ, UK.
  • Caimari F; Centre for Endocrinology, William Harvey Research Institute, Barts and The London School of Medicine, Queen Mary University of London, London, EC1M 6BQ, UK.
  • Grossman AB; Centre for Endocrinology, William Harvey Research Institute, Barts and The London School of Medicine, Queen Mary University of London, London, EC1M 6BQ, UK.
  • Crnogorac-Jurcevic T; Molecular Oncology, Barts Cancer Institute, Barts and The London School of Medicine, Queen Mary University of London, London, EC1M 6BQ, UK.
  • Haworth O; Centre for Endocrinology, William Harvey Research Institute, Barts and The London School of Medicine, Queen Mary University of London, London, EC1M 6BQ, UK.
  • Gaston-Massuet C; Centre for Endocrinology, William Harvey Research Institute, Barts and The London School of Medicine, Queen Mary University of London, London, EC1M 6BQ, UK.
  • Korbonits M; Centre for Endocrinology, William Harvey Research Institute, Barts and The London School of Medicine, Queen Mary University of London, London, EC1M 6BQ, UK. m.korbonits@qmul.ac.uk.
Oncogene ; 38(27): 5381-5395, 2019 07.
Article en En | MEDLINE | ID: mdl-30867568
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Neoplasias Hipofisarias / Péptidos y Proteínas de Señalización Intracelular / Microambiente Tumoral / Mutación / Invasividad Neoplásica Idioma: En Revista: Oncogene Asunto de la revista: BIOLOGIA MOLECULAR / NEOPLASIAS Año: 2019 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Neoplasias Hipofisarias / Péptidos y Proteínas de Señalización Intracelular / Microambiente Tumoral / Mutación / Invasividad Neoplásica Idioma: En Revista: Oncogene Asunto de la revista: BIOLOGIA MOLECULAR / NEOPLASIAS Año: 2019 Tipo del documento: Article